Hypersensitivity syndrome caused by amitriptyline administration | Zendy

Haralampos J. Milionis | Zendy; A. Skopelitou | Zendy; Moses Elisaf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Hypersensitivity syndrome caused by amitriptyline administration

Author(s) -

Haralampos J. Milionis,

A. Skopelitou,

Moses Elisaf

Publication year - 2000

Publication title -

postgraduate medical journal

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.568

H-Index - 99

eISSN - 1469-0756

pISSN - 0032-5473

DOI - 10.1136/pmj.76.896.361

Subject(s) - medicine , amitriptyline , discontinuation , hypersensitivity reaction , tricyclic , dermatology , hyperpigmentation , tricyclic antidepressant , adverse effect , delayed hypersensitivity , drug , antidepressant , anesthesia , pharmacology , immunology , antigen , hippocampus

Adverse cutaneous manifestations are among the most common side effects associated with psychotropic drugs. Skin reactions due to amitriptyline (a tricyclic antidepressant agent) include rashes and hypersensitivity reactions (for example, urticaria and photosensitivity) as well as hyperpigmentation. Hypersensitivity syndrome is a specific severe idiosyncratic reaction causing skin, liver, joint, and haematological abnormalities, which usually resolve after the discontinuation of the implicated drug. A case of a 24 year old woman who experienced hypersensitivity syndrome three weeks after the initiation of amitriptyline is reported.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research